サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1373906

局所麻酔薬市場：薬剤タイプ別、用途別、流通チャネル別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測

Local Anesthesia Drugs Market, By Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 334 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
局所麻酔薬市場：薬剤タイプ別、用途別、流通チャネル別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 334 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

局所麻酔薬の市場規模は2022年に27億8,030万米ドルとなり、2023年から2030年にかけてCAGR 6.6%で拡大

局所麻酔薬市場-市場力学

慢性疾患の増加が市場需要に拍車をかける

糖尿病やがんなどの慢性疾患の増加、およびこれらの疾患による入院費の高騰が、予測期間中の局所麻酔市場シェアの伸びを牽引しています。がん患者は、手術、麻酔、鎮痛剤、入院を必要とします。オピオイドや局所麻酔薬は、鎮痛治療のために処方されることが多いです。さらに、世界中で行われる手術の件数の増加は、事故、歯科治療、呼吸器疾患、神経疾患、がん、心血管疾患、胃腸疾患、脊椎疾患、整形外科疾患などの慢性疾患になりやすい加齢に関連した問題に起因しています。したがって、このような要因が局所麻酔薬の需要を促進する可能性が高いです。しかし、医療従事者や患者による局所麻酔の使用を必要としない非侵襲的手術の使用は、局所麻酔薬市場の収益成長を妨げると予想されます。さらに、局所麻酔薬は、医師だけでなく患者にも多くの利点を提供します。例えば、局所麻酔薬を注射するために、麻酔科医は必要ないです。医師や外科医は、手術を開始する前に局所麻酔薬を提供することができます。局所麻酔薬に関連する副作用はまれで、非常に軽度です。これに伴い、誤嚥性肺炎のリスクも少なく、手術の遅れもなく、患者は早期に帰宅することができます。これらの要因は、予測期間中、局所麻酔薬セクターにプラスの影響を与えると予測されます。

局所麻酔薬市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界の局所麻酔薬市場は予測期間（2023-2030年）に約6.6%のCAGRで毎年成長すると予測されています。

局所麻酔薬産業は、局所麻酔薬の多くの利点と慢性疾患の罹患率の上昇により、著しい速度で成長すると予測されています。

薬剤タイプ別では、リドカインが2022年に最大の市場シェアを示すと予測されます。

用途別では、注射剤が2022年の主要タイプでした。

全身麻酔に使用される薬剤は、処置中に患者を眠らせるため、局所麻酔薬とは異なります。

局所麻酔薬市場-セグメンテーション分析：

世界の局所麻酔薬市場は、薬剤の種類、用途、流通チャネル、地域によって区分されます。

薬剤の種類によって、ベンゾカイン、ブピバカイン、リドカイン、ロピバカイン、プリロカイン、クロロプロカイン、その他の6つに分類されます。リドカインセグメントが最も高い市場シェアを占めています。リドカインによる局所麻酔は、外科手術や注射の前に皮膚にしびれを生じさせるために広く使用されています。特定の医療処置の前に、リドカインクリームはしびれや感覚の喪失を誘発するために使用されます。これは、痛みの感覚を最小限に抑える体内の神経信号の伝達をブロックすることによって効率的に動作します。

市場は用途によって、表面麻酔剤と注射剤の2つに分類されます。予測期間中、最大の市場シェアを占めるのは注射剤であろう。注射用局所麻酔薬は長い間使用されており、かなり一般的です。さらに、費用対効果が高く、医療処置中のしびれのために必要とされます。局所麻酔薬は、脳と痛みの発生源との間を遮断する役割を果たし、一時的に神経の活動を抑制して脳に信号を伝達することで、患者にしびれ感をもたらします。

局所麻酔薬市場-地理的洞察

地域別分析によると、市場は北米、アジア太平洋、欧州、中東・アフリカ、中南米に分類されます。北米市場は、インフラ整備や技術進歩に伴うヘルスケア投資の増加により、優位に立つと予測されます。また、公的機関と民間機関が戦略的に協力・提携し、治療成績の向上に努めています。さらに、欧州は、術後緩和の需要、ジェネリック人口の増加、慢性疾患の増加により、第2位の市場になると推定されます。また、欧州地域は、革新的な製品を導入することで主要プレーヤーを増やすことにつながる、機器や器具に対する支援的な償還制度を有しているため、市場は収益を上げる可能性が高いです。

局所麻酔薬市場-競合情勢：

ヘルスケアへの支出の増加、新規パイプライン製品の発売の増加、研究開発活動の活発化、主要プレーヤーによる投資の急増が市場開拓を後押しします。さらに、麻酔薬ビジネスでは、合併という形での集中が一般的になりつつあります。これは主に、麻酔薬製造会社を立ち上げるために必要な多額の知的財産投資と研究開発投資によるものです。M&Aはこの面で費用対効果が高く、時間効率の良いアプローチと考えられています。例えば、2021年3月、パシラ・バイオサイエンシズ社は、米国食品医薬品局（FDA）が、EXPARELの添付文書を、術後局所鎮痛を目的とした単回用量浸潤の6歳以上の患者への使用を含むよう拡大することを求める追加新薬承認申請（sNDA）の提出を承認したと発表しました。EXPARELは、今回の承認により、FDAが承認した6歳以下の小児患者を対象とした最初で唯一の長時間作用型局所鎮痛薬となります。

目次

第1章 局所麻酔薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 局所麻酔薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 局所麻酔薬産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 局所麻酔薬市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 局所麻酔薬市場情勢

  • 局所麻酔薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 局所麻酔薬市場- 薬剤の種類別

  • 概要
    • 医薬品種類別セグメントシェア分析
    • ベンゾカイン
    • ブピバカイン
    • リドカイン
    • ロピバカイン
    • プリロカイン
    • クロロプロカイン
    • その他

第8章 局所麻酔薬市場- アプリケーション別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • 表面麻酔薬
    • 注射可能

第9章 局所麻酔薬市場- 流通チャネル別

  • 概要
    • 販売チャネル別のセグメントシェア分析
    • 薬局店舗
    • 病院薬局
    • その他

第10章 局所麻酔薬市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 局所麻酔薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pacira Pharmaceuticals, Inc.
    • Novartis AG
    • Aspen Pharmacare
    • Advanced Pharma, Inc.
    • Sagent Pharmaceuticals
    • Baxter International, Inc.
    • Hikma Pharmaceuticals plc
    • Teva Pharmaceutical Industries Ltd.
    • Akorn, Inc.
    • GSK plc.
    • Fresenius Kabi
    • Mylan NV
    • AstraZeneca plc

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Local Anesthesia Drugs Market: Drugs Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drugs Type
  • TABLE Global Local Anesthesia Drugs Market, by Drugs Type2018-2030 (USD Million)
  • TABLE Local Anesthesia Drugs Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Local Anesthesia Drugs Market, by Application2018-2030 (USD Million)
  • TABLE Local Anesthesia Drugs Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Local Anesthesia Drugs Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Local Anesthesia Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Local Anesthesia Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Local Anesthesia Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Local Anesthesia Drugs Market, by Drugs Type, 2018-2030 (USD Million)
  • TABLE North America Local Anesthesia Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Local Anesthesia Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Local Anesthesia Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Local Anesthesia Drugs Market, by Drugs Type, 2018-2030 (USD Million)
  • TABLE Europe Local Anesthesia Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Local Anesthesia Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Local Anesthesia Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Local Anesthesia Drugs Market, by Drugs Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Local Anesthesia Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Local Anesthesia Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Local Anesthesia Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Local Anesthesia Drugs Market, by Drugs Type, 2018-2030 (USD Million)
  • TABLE Latin America Local Anesthesia Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Local Anesthesia Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Local Anesthesia Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Local Anesthesia Drugs Market, by Drugs Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Local Anesthesia Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Local Anesthesia Drugs Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Local Anesthesia Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drugs Type segment market share analysis, 2022&2030
  • FIGURE Drugs Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022&2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Local Anesthesia Drugs Market share and leading players, 2022
  • FIGURE Europe Local Anesthesia Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Local Anesthesia Drugs Market share and leading players, 2022
  • FIGURE Latin America Local Anesthesia Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Local Anesthesia Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Local Anesthesia Drugs Market share analysis by country, 2022
  • FIGURE Germany Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Local Anesthesia Drugs Market share analysis by country, 2022
  • FIGURE India Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Local Anesthesia Drugs Market share analysis by country, 2022
  • FIGURE Brazil Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Local Anesthesia Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Local Anesthesia Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1791

REPORT HIGHLIGHT

Local anesthesia drugs market size was valued at USD 2,780.3 Million in 2022, expanding at a CAGR of 6.6% from 2023 to 2030.

Local anesthesia is a loss of sensation in a specific area or place of the body. Drugs that include local anesthetics are used to treat uncomfortable situations, relieve pain while performing minor or large surgeries, and reduce pain post-surgery. Additionally, some drugs act as local anesthetics at greater doses. Moreover, a local anesthetic can be directly administered to the affected area or it can be absorbed through the skin. The doctor might employ a different anesthetic that lasts 4 to 6 hours when a vast area requires to be numbed or medications may not work well enough.

Local Anesthesia Drugs Market- Market Dynamics

The rising prevalence of chronic diseases is fueling the market demand

Increasing cases of chronic diseases, such as diabetes and cancer as well as high hospitalization costs because of these diseases across the globe, is accounted to drive the local anesthesia market share growth during the forecast period. Patients suffering from cancer need surgery, anesthetic, pain medication, and hospitalization. Opioids and local anesthetics are often prescribed to treat analgesia. Additionally, rising incidences of surgeries performed around the world can be attributed to accidents, dental treatments, and age-related issue, which is more prone to chronic diseases including respiratory ailments, neurological disorders, cancer, cardiovascular disorders, gastro, spinal difficulties, and orthopedic. Thus, such factors are likely to propel the demand for local anesthesia drugs. However, the use of non-invasive surgeries that do not need the use of local anesthesia by healthcare professionals or patients is expected to hinder local anesthesia drugs market revenue growth. Furthermore, local anesthesia drugs provide numerous benefits to the doctor as well as the patient, for instance, for injecting local anesthesia drugs, anesthesiologist is not required. The doctors and surgeons can offer local anesthesia drugs before starting the operation of the procedure. The side effects related to local anesthesia drugs are uncommon and very mild. In line with this, due to these factors, there is less risk of aspiration pneumonia, no delay in the procedure, and patients can go home early. These factors are projected to have a positive impact on the local anesthesia drugs sector over the projection timeframe.

Local Anesthesia Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global local anesthesia drugs market is estimated to grow annually at a CAGR of around 6.6% over the forecast period (2023-2030)

The local anesthesia drugs industry is projected to grow at a significant rate due to the numerous benefits of local anesthesia drugs and rising incidence of chronic disease

Based on drug type segmentation, lidocaine was predicted to show maximum market share in the year 2022

Based on application segmentation, injectable was the leading type in 2022

Drugs used for general anesthesia lay the patient to sleep during the procedure and, therefore differ from local anesthetics.

Local Anesthesia Drugs Market- Segmentation Analysis:

The global local anesthesia drugs market is segmented on the basis of drug type, application, distribution channel, and region.

The market is divided into six categories based on drug type: benzocaine, bupivacaine, lidocaine, ropivacaine, prilocaine, chloroprocaine, and others. The lidocaine segment is attributed to dominate the highest market share. Local anesthesia is widely used by lidocaine to produce numbness on the skin before surgical procedures or injections. Before specific medical procedures lidocaine cream is used for inducing numbness or loss of feeling. It works efficiently by blocking the transmission of nerve signals in the body that minimize the pain sensation.

The market is divided into two categories based on applications: surface anesthetic and injectable. The injectable is likely to possess the largest market share during the forecast period. The injectable local anesthesia drugs have been in use for a long time and are quite common. Additionally, they are cost-effective and will be required for numbness during medical procedures. They act as a roadblock between the brain and the source of pain that temporarily inhibits the nerve's activity to transfer the signals to the brain thereby creating a feeling of numbness in patients.

Local Anesthesia Drugs Market- Geographical Insights

As per the geographical analysis, the market is classified into North America, Asia Pacific, Europe, Middle East & Africa, and Central & South America. The market for North America is projected to predominate due to increasing healthcare investments with improved infrastructure and technological advancements. Additionally, public and private agencies collaborate and partner strategically to improve outcomes in the treatment. Moreover, Europe is estimated to be the second-largest market owing to the demand for post-surgery relief, rising generic population, and increasing chronic diseases. The European region also has supportive reimbursement facilities for devices and instruments which will lead to an increasing key player by introducing innovative products and thus the market is more likely to generate revenue.

Local Anesthesia Drugs Market- Competitive Landscape:

The increasing spending on healthcare, increasing new pipeline product launches, increasing research & development activities, and burgeoning investments from key players will boost the market development. Moreover, growing concentration in the form of mergers is becoming more common in the anesthetics business. This is mostly due to the significant intellectual property investments and research & development investment needed to start anesthetic pharmaceutical manufacturing companies. Mergers and acquisitions are seen as cost-effective and time-efficient approaches in this aspect. For instance, in March 2021, Pacira BioSciences, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the submission of its supplemental new drug application (sNDA) seeking expansion of the EXPAREL label to involve use in patients 6 years of age and older for single-dose infiltration to develop postsurgical local analgesia. EXPAREL is the first and only FDA-approved long-acting local analgesic for the pediatric population as young as age six, with this approval.

Recent Developments:

For instance, in June 2023, Hikma Pharmaceuticals PLC launched Dobutamine Injection, USP, in a 250mg/20mL vial in the US. Hikma's extensive US portfolio of sterile injectable medicines now exceeds 150 products spanning a variety of therapeutic areas and dosage forms, with this launch.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LOCAL ANESTHESIA DRUGS MARKET KEY PLAYERS

  • Pacira Pharmaceuticals, Inc.
  • Novartis AG
  • Aspen Pharmacare
  • Advanced Pharma, Inc.
  • Sagent Pharmaceuticals
  • Baxter International, Inc.
  • Hikma Pharmaceuticals plc
  • Teva Pharmaceutical Industries Ltd.
  • Akorn, Inc.
  • GSK plc.
  • Fresenius Kabi
  • Mylan N.V.
  • AstraZeneca plc

GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY DRUG TYPE

  • Benzocaine
  • Bupivacaine
  • Lidocaine
  • Ropivacaine
  • Prilocaine
  • Chloroprocaine
  • Others

GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION

  • Surface Anesthetic
  • Injectable

GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Pharmacy Stores
  • Hospital Pharmacies
  • Others

GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Local Anesthesia Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Local Anesthesia Drugs Market Snippet by Drugs Type
    • 2.1.2. Local Anesthesia Drugs Market Snippet by Application
    • 2.1.3. Local Anesthesia Drugs Market Snippet by Distribution Channel
    • 2.1.4. Local Anesthesia Drugs Market Snippet by Country
    • 2.1.5. Local Anesthesia Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Local Anesthesia Drugs Key Market Trends

  • 3.1. Local Anesthesia Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Local Anesthesia Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Local Anesthesia Drugs Market Opportunities
  • 3.4. Local Anesthesia Drugs Market Future Trends

4. Local Anesthesia Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Local Anesthesia Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Local Anesthesia Drugs Market Landscape

  • 6.1. Local Anesthesia Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Local Anesthesia Drugs Market - By Drugs Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drugs Type, 2022&2030 (%)
    • 7.1.2. Benzocaine
    • 7.1.3. Bupivacaine
    • 7.1.4. Lidocaine
    • 7.1.5. Ropivacaine
    • 7.1.6. Prilocaine
    • 7.1.7. Chloroprocaine
    • 7.1.8. Others

8. Local Anesthesia Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Surface Anesthetic
    • 8.1.3. Injectable

9. Local Anesthesia Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
    • 9.1.2. Pharmacy Stores
    • 9.1.3. Hospital Pharmacies
    • 9.1.4. Others

10. Local Anesthesia Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Local Anesthesia Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Local Anesthesia Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Local Anesthesia Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Local Anesthesia Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Local Anesthesia Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Local Anesthesia Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pacira Pharmaceuticals, Inc.
    • 11.2.2. Novartis AG
    • 11.2.3. Aspen Pharmacare
    • 11.2.4. Advanced Pharma, Inc.
    • 11.2.5. Sagent Pharmaceuticals
    • 11.2.6. Baxter International, Inc.
    • 11.2.7. Hikma Pharmaceuticals plc
    • 11.2.8. Teva Pharmaceutical Industries Ltd.
    • 11.2.9. Akorn, Inc.
    • 11.2.10. GSK plc.
    • 11.2.11. Fresenius Kabi
    • 11.2.12. Mylan N.V.
    • 11.2.13. AstraZeneca plc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us